FDA.reportPublic FDA data

AnubisMed

Manufacturer
ANUBIS COSMETICS SL | GDC OF FLORIDA IMPORTS, INC.
Effective date
2023-09-05
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:56:06

Label at a glance#

ProductAnubisMed
Active ingredientGLYCOLIC ACID, KOJIC ACID, HEXYLRESORCINOL, ASCORBYL GLUCOSIDE, LACTIC ACID, PHENOXYETHANOL, PROPYLENE GLYCOL, HYDROXYETHYL CELLULOSE, UNSPECIFIED, ALCOHOL, AMMONIA, ISOPROPYL ALCOHOL, WATER, ETHYLHEXYLGLYCERIN, SALICYLIC ACID
Label structure9 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Resorcinol peel ingredientsResorcinol peel ingredients

INDICATIONS & USAGE SECTION

Resorcinol peel indicationsResorcinol peel indications

OTC - DO NOT USE SECTION

Resorcinol peel do not useResorcinol peel do not use

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Resorcinol peel keepResorcinol peel keep

DOSAGE & ADMINISTRATION SECTION

Resorcinol peel dosageResorcinol peel dosage

WARNINGS SECTION

Resorcinol peel warningsResorcinol peel warnings

INACTIVE INGREDIENT SECTION

Resorcinol peel ingredients listResorcinol peel ingredients list

OTC - PURPOSE SECTION

Resorcinol peel purposeResorcinol peel purpose

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Resorcinol peel displayResorcinol peel display

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LACTIC ACID, UNSPECIFIED FORM Pharmacologic Class Indexing1Indexing - Pharmacologic Class20220121

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83021-401-50AnubisMed50 mL in 1 BOTTLELIQUID502

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
83021-401ANUBISMED (GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID) LIQUID [ANUBIS COSMETICS SL]2Current NDC, Legacy NDC, 1 package rows20230906_eca95dde-cb57-2ab6-e053-2995a90af84f.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83021-40183021-401-50

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Name, UNII, Kind table
NameUNIIKind
GLYCOLIC ACID0WT12SX38SACTIB
KOJIC ACID6K23F1TT52ACTIB
HEXYLRESORCINOLR9QTB5E82NACTIB
ASCORBYL GLUCOSIDE2V52R0NHXWACTIB
LACTIC ACID33X04XA5ATACTIB
PHENOXYETHANOLHIE492ZZ3TACTIB
CITRIC ACID MONOHYDRATE2968PHW8QPIACT
PROPYLENE GLYCOL6DC9Q167V3ACTIB
HYDROXYETHYL CELLULOSE, UNSPECIFIEDT4V6TWG28DACTIB
ALCOHOL3K9958V90MACTIB
AMMONIA5138Q19F1XACTIB
ISOPROPYL ALCOHOLND2M416302ACTIB
SODIUM NITRATE8M4L3H2ZVZIACT
WATER059QF0KO0RACTIB
ETHYLHEXYLGLYCERIN147D247K3PACTIB
SALICYLIC ACIDO414PZ4LPZACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AnubisMedGLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACIDANUBIS COSMETICS SLeca95dde-cb57-2ab6-e053-2995a90af84f2023-09-05WarningsExact identifier
ndc (package): 83021-401-50
ndc (product): 83021-401
ndc11 (package): 83021040150
spl id: 049fdc9c-b52f-63c1-e063-6394a90aaa6a
spl set id: eca95dde-cb57-2ab6-e053-2995a90af84f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.